Appleton Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,292
| Closed | -$207K | – | 256 |
|
|
2024
Q3 | $207K | Sell |
3,292
-875
| -21% | -$51K | 0.02% | 253 |
|
|
2024
Q2 | $246K | Sell |
4,167
-468
| -10% | -$29.3K | 0.02% | 239 |
|
|
2024
Q1 | $370K | Sell |
4,635
-3,597
| -44% | -$275K | 0.03% | 210 |
|
|
2023
Q4 | $650K | Sell |
8,232
-1,919
| -19% | -$137K | 0.05% | 170 |
|
|
2023
Q3 | $709K | Sell |
10,151
-1,528
| -13% | -$108K | 0.06% | 159 |
|
|
2023
Q2 | $807K | Sell |
11,679
-1,027
| -8% | -$73.1K | 0.07% | 157 |
|
|
2023
Q1 | $944K | Sell |
12,706
-130
| -1% | -$10.9K | 0.08% | 156 |
|
|
2022
Q4 | $1.2M | Buy |
12,836
+500
| +4% | +$48.2K | 0.11% | 141 |
|
|
2022
Q3 | $1.18M | Buy |
12,336
+6,292
| +104% | +$623K | 0.12% | 136 |
|
|
2022
Q2 | $560K | Buy |
6,044
+940
| +18% | +$91.7K | 0.05% | 187 |
|
|
2022
Q1 | $517K | Sell |
5,104
-78
| -2% | -$8.19K | 0.04% | 214 |
|
|
2021
Q4 | $535K | Buy |
5,182
+775
| +18% | +$71.6K | 0.04% | 214 |
|
|
2021
Q3 | $374K | Buy |
4,407
+1,480
| +51% | +$124K | 0.03% | 225 |
|
|
2021
Q2 | $244K | Sell |
2,927
-291
| -9% | -$23.8K | 0.02% | 270 |
|
|
2021
Q1 | $242K | Sell |
3,218
-14
| -0.4% | -$1.02K | 0.02% | 263 |
|
|
2020
Q4 | $221K | Buy |
+3,232
| New | +$210K | 0.02% | 262 |
|
|
2020
Q1 | – | Sell |
-3,151
| Closed | -$234K | – | 263 |
|
|
2019
Q4 | $234K | Sell |
3,151
-137
| -4% | -$9.62K | 0.03% | 274 |
|
|
2019
Q3 | $207K | Buy |
+3,288
| New | +$195K | 0.03% | 270 |
|
|
2019
Q1 | – | Sell |
-4,592
| Closed | -$301K | – | 262 |
|
|
2018
Q4 | $301K | Buy |
4,592
+120
| +3% | +$8.96K | 0.05% | 209 |
|
|
2018
Q3 | $352K | Sell |
4,472
-338
| -7% | -$24.2K | 0.05% | 212 |
|
|
2018
Q2 | $310K | Sell |
4,810
-4,693
| -49% | -$309K | 0.04% | 218 |
|
|
2018
Q1 | $591K | Sell |
9,503
-2,906
| -23% | -$209K | 0.09% | 173 |
|
|
2017
Q4 | $900K | Sell |
12,409
-1,971
| -14% | -$143K | 0.14% | 141 |
|
|
2017
Q3 | $1.17M | Sell |
14,380
-3,461
| -19% | -$274K | 0.2% | 120 |
|
|
2017
Q2 | $1.44M | Sell |
17,841
-1,249
| -7% | -$98.6K | 0.24% | 101 |
|
|
2017
Q1 | $1.5M | Sell |
19,090
-4,585
| -19% | -$366K | 0.28% | 95 |
|
|
2016
Q4 | $1.87M | Sell |
23,675
-64,988
| -73% | -$5.26M | 0.38% | 72 |
|
|
2016
Q3 | $7.89M | Sell |
88,663
-3,362
| -4% | -$317K | 1.49% | 17 |
|
|
2016
Q2 | $8.81M | Buy |
92,025
+1,787
| +2% | +$178K | 1.8% | 11 |
|
|
2016
Q1 | $9.36M | Buy |
90,238
+64,389
| +249% | +$6.26M | 1.85% | 10 |
|
|
2015
Q4 | $2.53M | Buy |
25,849
+6,912
| +36% | +$677K | 0.5% | 65 |
|
|
2015
Q3 | $1.83M | Buy |
18,937
+5,838
| +45% | +$614K | 0.42% | 67 |
|
|
2015
Q2 | $1.37M | Buy |
13,099
+638
| +5% | +$65.2K | 0.31% | 74 |
|
|
2015
Q1 | $1.29M | Buy |
12,461
+2,315
| +23% | +$234K | 0.29% | 80 |
|
|
2014
Q4 | $977K | Buy |
10,146
+345
| +4% | +$30.4K | 0.22% | 90 |
|
|
2014
Q3 | $780K | Buy |
9,801
+955
| +11% | +$75.3K | 0.18% | 99 |
|
|
2014
Q2 | $667K | Buy |
8,846
+1,951
| +28% | +$147K | 0.16% | 102 |
|
|
2014
Q1 | $516K | Buy |
6,895
+580
| +9% | +$41K | 0.12% | 114 |
|
|
2013
Q4 | $452K | Buy |
6,315
+72
| +1% | +$4.63K | 0.11% | 112 |
|
|
2013
Q3 | $354K | Buy |
6,243
+1,583
| +34% | +$94.3K | 0.09% | 115 |
|
|
2013
Q2 | $266K | Buy |
+4,660
| New | +$270K | 0.08% | 127 |
|
Other funds holding CVS
Appleton Partners's CVS Position: Q4 2024 in Review
Appleton Partners sold out of CVS Health (CVS) in Q4 2024, closing a stake of 3,292 shares — an estimated $207K sold.
Appleton Partners first reported a position in CVS in Q2 2013 and held it in 41 quarters. The position peaked at $9.36M in Q1 2016. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.
- Appleton Partners reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
- Appleton Partners sold 3,292 CVS Health shares in Q4 2024, an estimated $207K.
- Appleton Partners first reported a position in CVS Health in Q2 2013 and held it in 41 quarters.
- Appleton Partners's CVS Health position peaked at $9.36M in Q1 2016.
- 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.
Based on Appleton Partners's 13F filing for Q4 2024, filed 28 Jan 2025.